This is the authors' abstract. We don't add key points for this paper.
The mammalian thioredoxin reductases (TrxRs) are a family of selenium-containing pyridine nucleotide disulfide oxidoreductases playing a central role in cellular redox homeostasis and signaling pathways. Recently, these selenoproteins have emerged as promising therapeutic targets for anticancer drug development, often being overexpressed in tumor cells and contributing to drug resistance. Herein, we summarize the current knowledge on metal- and semimetal-containing molecules capable of hampering mammalian TrxRs, with an emphasis on compounds reported in the last decade.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gandin et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: